IRCT20090117001556N138
Not yet recruiting
Phase 2
Investigating the effect of Famotidine on cognitive and behavioral dysfunctions induced by COVID-19: A randomized double blind and placebo controlled clinical trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- COVID-19.
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •History of hospitalization due to COVID\-19
- •At least 20 days from the onset of symptoms, and 7 days from the last day of symptoms passed
- •Diagnosis of cognitive impairment (score 23 or less in MMSE test, or score 22 or less in MoCA test)
- •Age between 18\-65
Exclusion Criteria
- •Being psychotic
- •Presence of other psychiatric disorders
- •Using other psychiatric drugs or any drug which can affect cognitive performance
- •History of ECT during past 2 months
- •Presence of thyroid disease
- •Presence of kidney disease
- •Presence of liver disease
- •History of cognitive impairment or dementia
- •Pregnant or lactating women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Evaluating the short-term effect of Fampridine on cognitive function in Multiple sclerosis patientsIRCT20161212031362N4Iranian Center of Neurological Research108
Recruiting
Phase 3
The effect of famotidine on reducing the side effects of prostate cancer radiotherapyIRCT20231121060132N1Kermanshah University of Medical Sciences50
Recruiting
Phase 3
Famotidine and COVID-19aboratory confirmed COVID-19.COVID-19, virus identifiedU07.1IRCT20200509047364N2Bandare-abbas University of Medical Sciences20
Completed
Not Applicable
Acute effects of modafinil on cognitive function and activation of prefrontal cortex in people with schizophreniaMental and Behavioural Disorders: SchizophreniaMental and Behavioural DisordersSchizophreniaISRCTN54567688Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)30
Not yet recruiting
Phase 1
The effect of fampiridine on optic nerve imaging in patients with Anterior Ischemic Optic neuropathyIRCT20151123025202N35Shahid Beheshti University of Medical Sciences40